BR112014015354A8 - composição de extratos enriquecidos com elagitaninos no bem-estar sexual - Google Patents

composição de extratos enriquecidos com elagitaninos no bem-estar sexual

Info

Publication number
BR112014015354A8
BR112014015354A8 BR112014015354A BR112014015354A BR112014015354A8 BR 112014015354 A8 BR112014015354 A8 BR 112014015354A8 BR 112014015354 A BR112014015354 A BR 112014015354A BR 112014015354 A BR112014015354 A BR 112014015354A BR 112014015354 A8 BR112014015354 A8 BR 112014015354A8
Authority
BR
Brazil
Prior art keywords
sexual
elagitanine
composition
enriched extracts
well
Prior art date
Application number
BR112014015354A
Other languages
English (en)
Other versions
BR112014015354A2 (pt
Inventor
Burki Carolina
Schoenlau Frank
Ferrari Victor
Original Assignee
Horphag Res Ip Qr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horphag Res Ip Qr Ltd filed Critical Horphag Res Ip Qr Ltd
Publication of BR112014015354A8 publication Critical patent/BR112014015354A8/pt
Publication of BR112014015354A2 publication Critical patent/BR112014015354A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

resumo composição de extratos enriquecidos com elagitaninos no bem-estar sexual. a presente invenção refere-se a uma composição que consiste em extratos enriquecidos com elagitaninos originados de extratos de plantas da família fagaceae, para utilização em um método para melhorar o desempenho ou bem-estar sexual de ambos os sexos, o aprimoramento sexual masculino, o tratamento ou a prevenção da disfunção sexual e a saúde do sistema vascular sexual de ambos os sexos.
BR112014015354A 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos no bem-estar sexual BR112014015354A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH20452011 2011-12-23
PCT/EP2012/076837 WO2013093096A1 (en) 2011-12-23 2012-12-21 Ellagitannins rich extracts composition in sexual wellness

Publications (2)

Publication Number Publication Date
BR112014015354A8 true BR112014015354A8 (pt) 2017-06-13
BR112014015354A2 BR112014015354A2 (pt) 2017-06-13

Family

ID=47557106

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112014015354A BR112014015354A2 (pt) 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos no bem-estar sexual
BR112014015358A BR112014015358A8 (pt) 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112014015358A BR112014015358A8 (pt) 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos

Country Status (15)

Country Link
US (2) US9066924B2 (pt)
EP (2) EP2800572B1 (pt)
JP (2) JP2015502170A (pt)
CN (2) CN104053444B (pt)
BR (2) BR112014015354A2 (pt)
CA (2) CA2859066C (pt)
DK (2) DK2800572T3 (pt)
HR (1) HRP20160758T1 (pt)
PL (1) PL2793905T3 (pt)
PT (1) PT2793905E (pt)
SG (4) SG10201602856YA (pt)
SI (1) SI2793905T1 (pt)
TW (1) TWI583390B (pt)
WO (2) WO2013093096A1 (pt)
ZA (2) ZA201403827B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10238684B2 (en) 2010-11-18 2019-03-26 Foundational Biosystems, Llc Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
FR3055215B1 (fr) * 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
CN108041588A (zh) * 2017-12-08 2018-05-18 冯纪敏 一种含有海藻糖的组合物及其应用
WO2019213464A1 (en) * 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal atrophy
EP3787656A1 (en) * 2018-05-04 2021-03-10 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
JP7185260B2 (ja) * 2018-06-18 2022-12-07 株式会社Active 悪夢障害の治療用医薬組成物
EP3813944A1 (en) * 2018-06-29 2021-05-05 The Procter & Gamble Company Vaginal care compositions
CN109287852B (zh) * 2018-09-18 2021-12-28 青岛农业大学 一种利用板栗花水提取物提高动物精液品质的方法
EP3891267A4 (en) * 2018-11-05 2022-08-24 MarvelBiome, Inc. MICROBIAL COMPOSITIONS WITH ELLAGITANNIN AND METHOD OF USE
IT202000004747A1 (it) * 2020-03-06 2021-09-06 A M Italy S R L Composizione per l’uso nella terapia, in particolare per la cura dell’ansia
FI20215341A1 (fi) 2021-03-25 2022-09-26 Finthinktur Oy Liuottimen avulla valmistettu uute ja menetelmä uutteen valmistamiseksi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000136145A (ja) * 1998-10-29 2000-05-16 Nikka Whisky Distilling Co Ltd 樽材抽出物
US8372454B2 (en) 1999-04-19 2013-02-12 Pom Wonderful Llc Methods of making pomegranate compounds for the treatment of erectile dysfunction
US20040247698A1 (en) 2003-06-04 2004-12-09 Valenzuela Cortes Carmen Maria Erectile Dysfunction Treatment
CN100566723C (zh) * 2004-09-13 2009-12-09 辻田隆广 衍生自壳斗植物的糖酶抑制剂及其应用
JP2006104067A (ja) * 2004-09-30 2006-04-20 Suntory Ltd 自律神経機能を調節する作用を有する香気組成物、およびその利用
JP4778813B2 (ja) * 2006-03-07 2011-09-21 株式会社ロッテ メチオニナーゼ阻害剤
WO2009114810A2 (en) * 2008-03-14 2009-09-17 The Florida International Uinversity Board Of Trustees Use of ellagitannins as inhibitors of bacterial quorum sensing
WO2011161655A1 (en) * 2010-06-25 2011-12-29 Horphag Research (Ip) Pre Ltd Composition for improving sexual wellness

Also Published As

Publication number Publication date
PT2793905E (pt) 2016-06-20
US20140322369A1 (en) 2014-10-30
SG11201403431WA (en) 2014-11-27
TW201340976A (zh) 2013-10-16
CN104271141A (zh) 2015-01-07
WO2013093096A1 (en) 2013-06-27
CA2859062A1 (en) 2013-06-27
SG10201602856YA (en) 2016-05-30
CN104053444B (zh) 2017-11-07
EP2793905B1 (en) 2016-04-06
JP2015511212A (ja) 2015-04-16
CA2859062C (en) 2019-10-29
JP2015502170A (ja) 2015-01-22
SG11201403425WA (en) 2014-10-30
DK2800572T3 (da) 2017-11-20
US9066924B2 (en) 2015-06-30
SG10201602847XA (en) 2016-05-30
CN104271141B (zh) 2017-08-18
JP5918389B2 (ja) 2016-05-18
BR112014015354A2 (pt) 2017-06-13
WO2013093102A1 (en) 2013-06-27
BR112014015358A2 (pt) 2017-06-13
CA2859066C (en) 2020-07-14
TWI583390B (zh) 2017-05-21
ZA201404005B (en) 2017-08-30
BR112014015358A8 (pt) 2017-06-13
HRP20160758T1 (hr) 2016-08-12
DK2793905T3 (en) 2016-08-01
PL2793905T3 (pl) 2016-10-31
EP2800572A1 (en) 2014-11-12
SI2793905T1 (sl) 2016-08-31
ZA201403827B (en) 2015-10-28
EP2793905A1 (en) 2014-10-29
WO2013093096A8 (en) 2014-11-27
CN104053444A (zh) 2014-09-17
CA2859066A1 (en) 2013-06-27
EP2800572B1 (en) 2017-08-16
US20140343134A1 (en) 2014-11-20
US9060999B2 (en) 2015-06-23

Similar Documents

Publication Publication Date Title
BR112014015354A2 (pt) composição de extratos enriquecidos com elagitaninos no bem-estar sexual
BR112012032632A2 (pt) composição para melhorar o vigor sexual
DOP2014000160A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
ECSP13012379A (es) Pirimidinas y triazinas condensadas y su uso
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
UY33396A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
CU20130137A7 (es) Derivados de ácido 3- fenilpropiónico ramificados y su uso
BR112014021104A2 (pt) métodos e composições para o tratamento da doença de huntington
BR112015024846A2 (pt) composições para utilização no estímulo do crescimento ósseo
EA201400119A1 (ru) Фармацевтическая композиция, способы лечения и их применение
MX359626B (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o afecciones asociadas con disfunción mitocondrial.
MX349886B (es) Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas.
BR112018007958A2 (pt) composições e métodos que usam um polifenol para a saúde musculoesquelética
CO2017001658A2 (es) Compuestos tricíclicos que contienen nitrógeno para el tratamiento de la infección por neisseria gonorrhoeae
BR112014031112A2 (pt) nanossistemas para formulação de biocidas eficazes de risco mínimo
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112018071467A2 (pt) método de tratamento ou prevenção de patologias hepáticas
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
GT201400223A (es) Sistemas y métodos para tratar una respuesta farmacodinámica adversa inducida por opioides
BR112017024304A2 (pt) processo para a preparação de um extrato de cérebro animal
BR112017026834A2 (pt) composição compreendendo vitaminas b e vitaminas c e seu uso
EP2585067A4 (en) COMPOUND FOR THE TREATMENT OF ENTEROVIRUS
FI20115165A0 (fi) Terapeuttisia ja diagnostisia menetelmiä
CL2017000884A1 (es) Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica
IN2014DN05865A (pt)

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2546 DE 22/10/2019 POR TER SIDO INDEVIDA.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL